Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011, Article ID 892624, 11 pages
http://dx.doi.org/10.1155/2011/892624
Review Article

Clinical Uses of Melatonin in Pediatrics

1Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Institute of Formation and Research “Marques de Valdecilla” (IFIMAV), 39011 Santander, Spain
2Department of Cellular and Structural Biology, University of Texas Health Science Centre, San Antonio, TX 78229, USA

Received 28 December 2010; Revised 31 March 2011; Accepted 8 April 2011

Academic Editor: Myron Genel

Copyright © 2011 Emilio J. Sánchez-Barceló et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. Lerner, J. D. Case, Y. Takahashi, T. H. Lee, and W. Mori, “Isolation of melatonin, the pineal gland factor that lightens melanocytes,” Journal of the American Chemical Society, vol. 80, no. 10, p. 2587, 1958. View at Google Scholar
  2. E. J. Sanchez-Barceló, M. D. Mediavilla, D. X. Tan, and R. J. Reiter, “Clinical uses of melatonin: evaluation of human trials,” Current Medicinal Chemistry, vol. 17, no. 19, pp. 2070–2095, 2010. View at Google Scholar
  3. E. Gitto, S. Aversa, R. J. Reiter et al., “Update on the use of melatonin in pediatrics,” Journal of Pineal Research, vol. 50, no. 1, pp. 21–28, 2010. View at Google Scholar
  4. V. Srinivasan, S. R. Pandi-Perumal, I. Trahkt et al., “Melatonin and melatonergic drugs on sleep: possible mechanisms of action,” International Journal of Neurosciences, vol. 119, no. 6, pp. 821–846, 2009. View at Google Scholar
  5. R. Carr, M. B. Wasdell, D. Hamilton et al., “Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders,” Journal of Pineal Research, vol. 43, no. 4, pp. 351–359, 2007. View at Google Scholar
  6. J. C. Blader, H. S. Koplewicz, H. Abikoff, and C. Foley, “Sleep problems of elementary school children: a community survey,” Archives of Pediatrics & Adolescent Medicine, vol. 151, no. 5, pp. 473–480, 1997. View at Google Scholar
  7. J. A. Owens, C. L. Rosen, and J. A. Mindell, “Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians,” Pediatrics, vol. 111, no. 5, pp. e628–e635, 2003. View at Google Scholar
  8. A. Cagnacci, J. A. Elliott, and S. S. Yen, “Melatonin a major regulator of the circadian rhythm of core temperature in humans,” Journal of Clinical Endocrinology & Metabolism, vol. 75, no. 2, pp. 447–452, 1992. View at Google Scholar
  9. O. Tzischinsky, A. Shlitner, and P. Lavie, “The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulphatoxymelatonin,” Journal of Biological Rhythms, vol. 8, no. 3, pp. 199–209, 1993. View at Google Scholar
  10. I. V. Zhdanova and R. J. Wurtman, “Efficacy of melatonin as a sleep-promoting agent,” Journal of Biolology Rhythms, vol. 112, no. 6, pp. 644–650, 1997. View at Google Scholar
  11. A. Brzezinski, “Melatonin in humans,” The New England Journal of Medicine, vol. 336, no. 3, pp. 186–195, 1997. View at Google Scholar
  12. M. L. Dubocovich, “Melatonin receptors role on sleep and circadian rhythm regulation,” Sleep Medicine, vol. 8, no. 3, pp. 34–42, 2007. View at Google Scholar
  13. American Academy of Sleep Medicine, ICSD-International Classification of Sleep Disorders: Diagnostic and Coding Manual, American Academy of Sleep Medicine, 2001.
  14. E. D. Weitzman, C. A. Czeisler, R. M. Coleman et al., “Delayed sleep phase syndrome. a chronobiological disorder with sleep-onset insomnia,” Archives of General Psychiatry, vol. 38, no. 7, pp. 737–746, 1981. View at Google Scholar
  15. S. A. Rahman, L. Kayumov, E. A. Tchmoutina, and C. M. Shapiro, “Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome,” Sleep Medicine, vol. 10, no. 5, pp. 549–555, 2009. View at Google Scholar
  16. T. I. Morgenthaler, T. Lee-Chiong, C. Alessi et al., “Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. an American academy of sleep medicine report,” Sleep, vol. 30, no. 11, pp. 1445–1459, 2007. View at Google Scholar
  17. A. Szeinberg, K. Borodkin, and Y. Dagan, “Melatonin treatment in adolescents with delayed sleep phase syndrome,” Clinical Pediatrics, vol. 45, no. 9, pp. 809–818, 2006. View at Google Scholar
  18. A. J. Lewy and R. L. Sack, “The dim light melatonin onset as a marker for circadian phase position,” Chronobiology International, vol. 6, no. 1, pp. 93–102, 1989. View at Google Scholar
  19. E. B. Klerman, H. B. Gershengorn, J. F. Duffy, and R. E. Kronauer, “Comparisons of the variability of three markers of the human circadian pacemaker,” Journal of Biological Rhythms, vol. 17, no. 2, pp. 181–193, 2002. View at Google Scholar
  20. K. Mundey, S. Benloucif, K. Harsanyi, M. L. Dubocovich, and P. C. Zee, “Phase-dependent treatment of delayed sleep phase syndrome with melatonin,” Sleep, vol. 28, no. 10, pp. 1271–1278, 2005. View at Google Scholar
  21. I. M. van Geijlswijk, K. B. van der Heijden, A. C. Egberts et al., “Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT,” Psychopharmacology, vol. 212, no. 3, pp. 379–391, 2010. View at Google Scholar
  22. R. L. Sack, D. Auckley, R. R. Auger et al., “Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm: an American academy of sleep medicine review,” Sleep, vol. 30, no. 11, pp. 1484–1501, 2007. View at Google Scholar
  23. R. Didden, H. Korzilius, B. van Aperlo, C. van Overloop, and M. de Vries, “Sleep problems and daytime problem behaviours in children with intellectual disability,” Journal of Intellectual Disability Research, vol. 46, no. 7, pp. 537–547, 2002. View at Publisher · View at Google Scholar
  24. J. E. Jan, D. Hamilton, N. Seward, D. K. Fast, R. D. Freeman, and M. Laudon, “Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders,” Journal of Pineal Research, vol. 29, no. 1, pp. 34–39, 2000. View at Publisher · View at Google Scholar
  25. W. Braam, M. G. Smits, R. Didden, H. Korzilius, I. M. van Geijlswijk, and L. M. G. Curfs, “Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis,” Developmental Medicine & Child Neurology, vol. 51, no. 5, pp. 340–349, 2009. View at Publisher · View at Google Scholar
  26. J. E. Jan, H. Espezel, and R. E. Appleton, “The treatment of sleep disorders with melatonin,” Developmental Medicine & Child Neurology, vol. 36, no. 2, pp. 97–107, 1994. View at Google Scholar
  27. I. V. Zhdanova, R. J. Wurtman, and J. Wagstaff, “Effects of a low dose of melatonin on sleep in children with angelman syndrome,” Journal of Pediatric Endocrinology & Metabolism, vol. 12, no. 1, pp. 57–67, 1999. View at Publisher · View at Google Scholar
  28. G. Pillar, E. Shahar, N. Peled, S. Ravid, P. Lavie, and A. Etzioni, “Melatonin improves sleep-wake patterns in psychomotor retarded children,” Pediatric Neurology, vol. 23, no. 3, pp. 225–228, 2000. View at Publisher · View at Google Scholar
  29. M. A. Gordo, J. Recio, and E. J. Sanchez-Barcelo, “Decreased sleep quality in patients suffering from retinitis pigmentosa,” Journal of Sleep Research, vol. 10, no. 2, pp. 159–164, 2001. View at Publisher · View at Google Scholar
  30. L. Palm, G. Blennow, and L. Wetterberg, “Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy,” Annals of Neurology, vol. 29, no. 3, pp. 336–339, 1991. View at Publisher · View at Google Scholar
  31. K. Ramstad and J. H. Loge, “Melatonin treatment of chronic sleep-wake cycle disorder in a blind retarded child,” Tidsskrift for den Norske Laegeforening, vol. 122, no. 10, pp. 1005–1006, 2002. View at Google Scholar
  32. A. Cavallo, W. V. Good, M. Douglas Ris, and P. Succop, “Dose response to melatonin treatment for disordered sleep rhythm in a blind child,” Sleep Medicine, vol. 3, no. 2, pp. 159–161, 2002. View at Publisher · View at Google Scholar
  33. L. Palm, G. Blennow, and L. Wetterberg, “Long term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances,” Developmental Medicine & Child Neurology, vol. 39, no. 5, pp. 319–325, 1997. View at Google Scholar
  34. O. Tzischinsky, D. Skene, R. Epstein, and P. Lavie, “Circadian rhythms in 6-sulphatoxymelatonin and nocturnal sleep in blind children,” Chronobiology International, vol. 8, no. 3, pp. 168–175, 1991. View at Publisher · View at Google Scholar
  35. B. V. Davitt, C. Morgan, and O. A. Cruz, “Sleep disorders in children with congenital anophthalmia and microphthalmia,” Journal of the American Association for Pediatric Ophthalmology and Strabismus, vol. 1, no. 3, pp. 151–153, 1997. View at Publisher · View at Google Scholar
  36. S. Miano and R. Ferri, “Epidemiology and management of insomnia in children with autistic spectrum disorders,” Pediatric Drugs, vol. 12, no. 2, pp. 75–84, 2010. View at Publisher · View at Google Scholar
  37. F. Cortesi, F. Giannotti, A. Ivanenko, and K. Johnson, “Sleep in children with autistic spectrum disorder,” Sleep Medicine, vol. 11, no. 7, pp. 659–664, 2010. View at Publisher · View at Google Scholar
  38. S. Tordjman, G. M. Anderson, N. Pichard, H. Charbuy, and Y. Touitou, “Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder,” Biological Psychiatry, vol. 57, no. 2, pp. 134–138, 2005. View at Publisher · View at Google Scholar
  39. J. Melke, H. Goubran Botros, P. Chaste et al., “Abnormal melatonin synthesis in autism spectrum disorders,” Molecular Psychiatry, vol. 13, no. 1, pp. 90–98, 2008. View at Publisher · View at Google Scholar
  40. L. Jonsson, E. Ljunggren, A. Bremer et al., “Mutation screening of melatonin-related genes in patients with autism spectrum disorders,” BMC Medical Genomics, vol. 3, article 10, 2010. View at Google Scholar
  41. P. Chaste, N. Clement, O. Mercati et al., “Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population,” PLoS One, vol. 5, no. 7, Article ID 11495, 2010. View at Google Scholar
  42. F. Guénolé, R. Godbout, A. Nicolas et al., “Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussio,” Sleep Medicine Reviews. In press. View at Publisher · View at Google Scholar
  43. C. Doyen, D. Mighiu, K. Kaye et al., “Melatonin in children with autistic spectrum disorders: recent and practical data,” European Child & Adolescent Psychiatry, vol. 20, no. 5, pp. 231–239, 2011. View at Publisher · View at Google Scholar
  44. E. J. Paavonen, T. Nieminen-von Wendt, R. Vanhala, E. T. Aronen, and L. Von Wendt, “Effectiveness of melatonin in the treatment of sleep disturbances in children with asperger disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 13, no. 1, pp. 83–95, 2003. View at Publisher · View at Google Scholar
  45. J. Garstang and M. Wallis, “Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems,” Child: Care, Health Development, vol. 32, no. 5, pp. 585–589, 2006. View at Publisher · View at Google Scholar
  46. F. Giannotti, F. Cortesi, A. Cerquiglini, and P. Bernabei, “An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autis,” Journal of Autism and Developmental Disorders, vol. 36, no. 6, pp. 741–752, 2006. View at Publisher · View at Google Scholar
  47. M. B. Wasdell, J. E. Jan, M. M. Bomben et al., “A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities,” Journal of Pineal Research, vol. 44, no. 1, pp. 57–64, 2008. View at Google Scholar
  48. I. M. Andersen, J. Kaczmarska, S. G. McGrew, and B. A. Malow, “Melatonin for insomnia in children with autism spectrum disorders,” Journal of Child Neurology, vol. 23, no. 5, pp. 482–485, 2008. View at Publisher · View at Google Scholar
  49. J. Wirojanan, S. Jacquemont, R. Diaz et al., “The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome,” Journal of Clinical Sleep Medicine, vol. 5, no. 2, pp. 145–150, 2009. View at Google Scholar
  50. B. Wright, D. Sims, S. Smart et al., “Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial,” Journal of Autism and Developmental Disorders, vol. 41, no. 2, pp. 175–184, 2011. View at Publisher · View at Google Scholar
  51. G. Galli-Carminati, N. Deriaz, and G. Bertschy, “Melatonin in the treatment of chronic sleep disorders in adults with autism: a retrospective study,” Swiss Medical Weekly, vol. 139, no. 19-20, pp. 293–296, 2009. View at Google Scholar
  52. M. D. Weiss and J. Salpekar, “Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments,” CNS Drugs 24, vol. 24, no. 10, pp. 811–828, 2010. View at Publisher · View at Google Scholar
  53. M. D. Weiss, M. B. Wasdell, M. M. Bomben, K. J. Rea, and R. D. Freeman, “Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 45, no. 5, pp. 512–519, 2006. View at Google Scholar
  54. K. B. van Der Heijden, M. G. Smits, E. J. van Someren, K. R. Ridderinkhof, and W. B. Gunning, “Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 46, no. 2, pp. 233–241, 2007. View at Publisher · View at Google Scholar
  55. M. Hoebert, K. B. van der Heijden, I. M. van Geijlswijk, and M. G. Smits, “Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia,” Journal of Pineal Research, vol. 47, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar
  56. L. M. Bendz and A. C. Scates, “Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder,” Annals of Pharmacotherapy, vol. 44, no. 1, pp. 185–191, 2010. View at Publisher · View at Google Scholar
  57. A. C. Smith, L. McGavran, J. Robinson et al., “Interstitial deletion of (17)(p11.2p11.2) in nine patients,” American Journal of Medical Genetics, vol. 24, no. 3, pp. 393–414, 1986. View at Publisher · View at Google Scholar
  58. A. L. Gropman, S. Elsea, W. C. Duncan Jr., and A. C. Smith, “New developments in smith-magenis syndrome (del 17p11.2),” Current Opinion in Neurology, vol. 20, no. 2, pp. 125–134, 2007. View at Publisher · View at Google Scholar
  59. H. De Leersnyder, J. L. Bresson, M. C. De Blois et al., “Beta 1-adrenergic antagonist and melatonin reset the clock and restore sleep in a circadian disorder, smith-magenis syndrome,” Journal of Medical Genetics, vol. 40, no. 1, pp. 74–78, 2003. View at Publisher · View at Google Scholar
  60. P. Mariotti, G. Della Marca, L. Iuvone et al., “Sleep disorders in sanfilippo syndrome: a polygraphic study,” Clinical Electroencephalography, vol. 34, no. 1, pp. 18–22, 2003. View at Google Scholar
  61. L. Potocki, D. Glaze, D. X. Tan et al., “Circadian rhythm abnormalities of melatonin in smith-magenis syndrome,” Journal of Medical Genetics, vol. 37, no. 6, pp. 428–433, 2000. View at Publisher · View at Google Scholar
  62. J. M. Guerrero, D. Pozo, J. L. Diaz-Rodriguez, F. Martinez-Cruz, and F. Vela-Campos, “Impairment of the melatonin rhythm in children with sanfilippo syndrome,” Journal of Pineal Research, vol. 40, no. 2, pp. 192–193, 2006. View at Publisher · View at Google Scholar
  63. H. De Leersnyder, B. Claustrat, A. Munnich, and A. Verloes, “Circadian rhythm disorder in a rare disease: smith-magenis syndrome,” Molecular and Cellular Endocrinology, vol. 252, no. 1-2, pp. 88–91, 2006. View at Publisher · View at Google Scholar
  64. R. Carpizo, A. Martínez, D. Mediavilla, M. González, A. Abad, and E. J. Sánchez-Barceló, “Smith-magenis syndrome: a case report of improved sleep after treatment with β1-adrenergic antagonists and melatonin,” Journal of Pediatrics, vol. 149, no. 3, pp. 409–411, 2006. View at Publisher · View at Google Scholar
  65. J. Fraser, J. E. Wraith, and M. B. Delatycki, “Sleep disturbance in mucopolysaccharidosis type III (sanfilippo syndrome): a survey of managing clinician,” Clinical Electroencephalography, vol. 62, no. 5, pp. 418–421, 2002. View at Google Scholar
  66. J. Fraser, A. A. Gason, J. E. Wraith, and M. B. Delatycki, “Sleep disturbance in sanfilippo syndrome: a parental questionnaire study,” Archives of Disease in Childhood, vol. 90, no. 12, pp. 1239–1242, 2005. View at Publisher · View at Google Scholar
  67. M. Ebadi, P. Govitrapong, P. Phansuwan-Pujito, F. Nelson, and R. J. Reiter, “Pineal opioid receptors and analgesic action of melatonin,” Journal of Pineal Research, vol. 24, no. 4, pp. 193–200, 1998. View at Publisher · View at Google Scholar
  68. M. Naguib, V. Gottumukkala, and P. A. Goldstein, “Melatonin and anesthesia: a clinical perspective,” Journal of Pineal Research, vol. 42, no. 1, pp. 12–21, 2007. View at Publisher · View at Google Scholar
  69. A. Samarkandi, M. Naguib, W. Riad et al., “Melatonin vs. midazolam premedication in children: a double-blind, placebo-controlled study,” European Journal of Anaesthesiology, vol. 22, no. 3, pp. 189–196, 2005. View at Google Scholar
  70. Z. N. Kain, J. E. Maclaren, L. Herrmann et al., “Preoperative melatonin and its effects on induction and emergence in children undergoing anesthesia and surgery,” Anesthesiology, vol. 111, no. 1, pp. 44–49, 2009. View at Publisher · View at Google Scholar
  71. B. Isik, O. Baygin, and H. Bodur, “Premedication with melatonin vs midazolam in anxious children,” Paediatric Anaesthesia, vol. 18, no. 7, pp. 635–641, 2008. View at Publisher · View at Google Scholar
  72. C. M. Schmidt, A. Knief, D. Deuster, P. Matulat, and A. G. Zehnhoff-Dinnesen, “Melatonin is a useful alternative to sedation in children undergoing brainstem audiometry with an age dependent success rate—a field report of 250 investigations,” Neuropediatrics, vol. 38, no. 1, pp. 2–4, 2007. View at Publisher · View at Google Scholar
  73. K. Johnson, A. Page, H. Williams, E. Wassemer, and W. Whitehouse, “The use of melatonin as an alternative to sedation in uncooperative children undergoing an MRI examination,” Clinical Radiology, vol. 57, no. 6, pp. 502–506, 2002. View at Publisher · View at Google Scholar
  74. M. R. Sury and K. Fairweather, “The effect of melatonin on sedation of children undergoing magnetic resonance imaging,” British Journal of Anaesthesia, vol. 97, no. 2, pp. 220–225, 2006. View at Publisher · View at Google Scholar
  75. R. J. Reiter, D. E. Blask, J. A. Talbot, and M. P. Barnett, “Nature and the time course of seizures associated with surgical removal of the pineal gland from parathyroidectomized rats,” Experimental Neurology, vol. 38, pp. 386–397, 1973. View at Publisher · View at Google Scholar
  76. R. G. Fariello, G. A. Bubenik, G. M. Brown et al., “Epileptogenic action of intraventricularly injected antimelatonin antibody,” Neurology, vol. 27, no. 6, pp. 267–270, 1997. View at Google Scholar
  77. H. Manev, U. Z. Tolga, A. Kharlamov, and J. Y. Joo, “Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats,” FASEB Journal, vol. 10, no. 13, pp. 1546–1551, 1996. View at Google Scholar
  78. C. W. Bazil, D. Short, D. Crispin, and W. Zheng, “Patients with intractable epilepsy have low melatonin, which increases following seizures,” Neurology, vol. 55, no. 11, pp. 1746–1748, 2000. View at Google Scholar
  79. A. Muñoz-Hoyos, M. Sánchez-Forte, A. Molina-Carballo et al., “Melatonin' s role as an anticonvulsant and neuronal protector: experimental and clinical evidence,” Journal of Child Neurology, vol. 13, no. 10, pp. 501–509, 1998. View at Publisher · View at Google Scholar
  80. A. Molina-Carballo, A. Muñoz-Hoyos, M. Sánchez-Forte, J. Uberos-Fernández, F. Moreno-Madrid, and D. Acuña-Castroviejo, “Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations,” Neuropediatrics, vol. 38, no. 3, pp. 122–125, 2007. View at Publisher · View at Google Scholar
  81. J. F. Guo and B. Z. Yao, “Serum melatonin levels in children with epilepsy or febrile seizures,” Zhongguo Dang Dai Er Ke Za Zhi, vol. 11, no. 4, pp. 288–290, 2009. View at Google Scholar
  82. J. Paprocka, R. Dec, E. Jamroz et al., “Melatonin and childhood refractory epilepsy—a pilot study,” Medical Science Monitor, vol. 16, no. 9, pp. 389–396, 2010. View at Google Scholar
  83. J. Fauteck, H. Schmidt, A. Lerchl, G. Kurlemann, and W. Wittkowski, “Melatonin in epilepsy: first results of replacement therapy and first clinical results,” Biological Signals and Receptors, vol. 8, no. 1-2, pp. 105–110, 1999. View at Publisher · View at Google Scholar
  84. A. Molina-Carballo, A. Muñoz-Hoyos, R. J. Reiter et al., “Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience,” Journal of Pineal Research, vol. 23, no. 2, pp. 97–105, 1997. View at Publisher · View at Google Scholar
  85. N. Peled, Z. Shorer, E. Peled, and G. Pillar, “Melatonin effect on seizures in children with severe neurologic deficit disorders,” Epilepsia, vol. 42, no. 9, pp. 1208–1210, 2001. View at Google Scholar
  86. J. Saracz and B. Rosdy, “Effect of melatonin on intractable epilepsies,” The Orvosi Hetilap, vol. 145, no. 51, pp. 2583–2587, 2004. View at Google Scholar
  87. S. H. Sheldon, “Pro-convulsant effects of oral melatonin in neurologically disabled children,” The Lancet, vol. 351, no. 9111, p. 1254, 1998. View at Publisher · View at Google Scholar
  88. C. Jones, M. Huyton, and D. Hindley, “Melatonin and epilepsy,” Archives of Disease in Childhood, vol. 90, no. 11, p. 1203, 2005. View at Google Scholar
  89. M. Gupta, Y. K. Gupta, S. Agarwal, S. Aneja, M. Kalaivani, and K. Kohli, “Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial,” Epilepsia, vol. 45, no. 12, pp. 1636–1639, 2004. View at Publisher · View at Google Scholar
  90. M. Gupta, Y. K. Gupta, S. Agarwal, S. Aneja, and K. Kohli, “A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes,” British Journal of Clinical Pharmacology, vol. 58, no. 5, pp. 542–547, 2004. View at Publisher · View at Google Scholar
  91. M. Gupta, S. Aneja, and K. Kohli, “Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial,” Epilepsy and Behavior, vol. 5, no. 3, pp. 316–321, 2004. View at Publisher · View at Google Scholar
  92. G. Coppola, G. Iervolino, M. Mastrosimone, G. La Torre, F. Ruiu, and A. Pascotto, “Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial,” Brain and Development, vol. 26, no. 6, pp. 373–376, 2004. View at Publisher · View at Google Scholar
  93. H. A. Elkhayat, S. M. Hassanein, H. Y. Tomoum, I. A. Abd-Elhamid, T. Asaad, and A. S. Elwakkad, “Melatonin and sleep-related problems in children with intractable epilepsy,” Pediatric Neurology, vol. 42, no. 4, pp. 249–254, 2010. View at Publisher · View at Google Scholar
  94. K. Fenoglio-Simeone, A. Mazarati, S. Sefidvash-Hockley et al., “Anticonvulsant effects of the selective melatonin receptor agonist ramelteon,” Epilepsy and Behavior, vol. 16, no. 1, pp. 52–57, 2009. View at Publisher · View at Google Scholar
  95. A. Moreau, M. Y. Akoumé Ndong, B. Azeddine et al., “Molecular and genetic aspects of idiopathic scoliosis: blood test for idiopathic scoliosis,” Orthopade, vol. 38, no. 2, pp. 114–121, 2009. View at Publisher · View at Google Scholar
  96. E. J. Sanchez-Barcelo, M. D. Mediavilla, D. X. Tan et al., “Scientific basis for the potencial use of melatonin in bone diseases: osteoporosis and adolescent Idiopathic scoliosis,” Journal of Osteoporosis, vol. 2010, Article ID 830231, 10 pages, 2010. View at Google Scholar
  97. M. Sadat-Ali, I. Al-Habdan, and A. Al-Othman, “Adolescent idiopathic scoliosis. is low melatonin a cause?” Joint Bone Spine, vol. 67, no. 1, pp. 62–64, 2000. View at Google Scholar
  98. K. M. Bagnall, V. J. Raso, D. L. Hill et al., “Melatonin levels in idiopathic scoliosis: diurnal and nocturnal serum melatonin levels in girls with adolescent idiopathic scoliosis,” Spine, vol. 21, no. 17, pp. 1974–1978, 1996. View at Publisher · View at Google Scholar
  99. A. S. Hilibrand, L. C. Blakemore, R. T. Loder et al., “The role of melatonin in the pathogenesis of adolescent idiopathic scoliosis,” Spine, vol. 21, no. 10, pp. 1140–1146, 1996. View at Publisher · View at Google Scholar
  100. A. B. Fagan, D. J. Kennaway, and A. D. Sutherland, “Total 24-hour melatonin secretion in adolescent idiopathic scoliosis: a case-control study,” Spine, vol. 23, no. 1, pp. 41–46, 1998. View at Publisher · View at Google Scholar
  101. W. Brodner, P. Krepler, M. Nicolakis et al., “Melatonin and adolescent idiopathic scoliosis,” Journal of Bone and Joint Surgery. British, vol. 82, no. 3, pp. 399–403, 2000. View at Publisher · View at Google Scholar
  102. K. T. Suh, S. S. Lee, S. J. Kim et al., “Pineal gland metabolism in patients with adolescent idiopathic scoliosis,” Journal of Bone and Joint Surgery. British, vol. 89, no. 1, pp. 66–71, 2007. View at Publisher · View at Google Scholar
  103. X. S. Qiu, N. L. Tang, H. Y. Yeung et al., “Melatonin receptor 1B (MTNR1B) gene polymorphism is associated with the occurrence of adolescent idiopathic scoliosis,” Spine, vol. 32, no. 16, pp. 1748–1753, 2007. View at Publisher · View at Google Scholar
  104. X. S. Qiu, N. L. Tang, H. Y. Yeung et al., “Lack of association between the promoter polymorphism of the MTNR1A gene and adolescent idiopathic scoliosis,” Spine, vol. 33, no. 20, pp. 2204–2207, 2008. View at Publisher · View at Google Scholar
  105. J. A. Morcuende, R. Minhas, L. Dolan et al., “Allelic variants of human melatonin 1A receptor in patients with familial adolescent idiopathic scoliosis,” Spine, vol. 28, no. 17, pp. 2025–2029, 2003. View at Publisher · View at Google Scholar
  106. H. Wang, Z. Wu, Q. Zhuang et al., “Association study of tryptophan hydroxylase 1 and arylalkylamine N-acetyltransferase polymorphisms with adolescent idiopathic scoliosis in han chinese,” Spine, vol. 33, no. 20, pp. 2199–2203, 2008. View at Publisher · View at Google Scholar
  107. J. Wu, Y. Qiu, L. Zhang et al., “Association of estrogen receptor gene polymorphisms with susceptibility to adolescent idiopathic scoliosis,” Spine, vol. 31, no. 10, pp. 1131–1136, 2006. View at Publisher · View at Google Scholar
  108. Y. Qiu, L. Wu, B. Wang, Y. Yu, and Z. Zhu, “Asymmetric expression of melatonin receptor mRNA in bilateral paravertebral muscles in adolescent idiopathic scoliosis,” Spine, vol. 32, no. 6, pp. 667–672, 2007. View at Publisher · View at Google Scholar
  109. A. Moreau, D. S. Wang, S. Forget et al., “Melatonin signaling dysfunction in adolescent idiopathic scoliosis,” Spine, vol. 29, no. 16, pp. 1772–1781, 2004. View at Publisher · View at Google Scholar
  110. B. Azeddine, K. Letellier, D. S. Wang et al., “Molecular determinants of melatonin signalling dysfunction in adolescent idiopathic scoliosis,” Clinical Orthopaedics and Related Research, no. 462, pp. 45–52, 2007. View at Google Scholar
  111. M. Y. Akoume, B. Azeddine, I. Turgeon et al., “Cell-based screening test for idiopathic scoliosis using cellular dielectric spectroscopy,” Spine, vol. 35, no. 13, pp. E601–E608, 2010. View at Google Scholar
  112. M. MacHida, J. Dubousset, T. Yamada, and J. Kimura, “Serum melatonin levels in adolescent idiopathic scoliosis prediction and prevention for curve progression—a prospective study,” Journal of Pineal Research, vol. 46, no. 3, pp. 344–348, 2009. View at Publisher · View at Google Scholar
  113. E. Gitto, S. Pellegrino, P. Gitto, I. Barberi, and R. J. Reiter, “Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin,” Journal of Pineal Research, vol. 46, no. 2, pp. 128–139, 2009. View at Publisher · View at Google Scholar
  114. F. Fulia, E. Gitto, S. Cuzzocrea et al., “Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin,” Journal of Pineal Research, vol. 31, no. 4, pp. 343–349, 2001. View at Publisher · View at Google Scholar
  115. E. Gittto, M. Karbownik, R. J. Reiter et al., “Effects of melatonin treatment in septic newborns,” Pediatric Research, vol. 50, no. 6, pp. 756–760, 2001. View at Publisher · View at Google Scholar
  116. E. Gitto, J. R. Reiter, S. Cordaro et al., “Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin,” Pediatrics, vol. 21, no. 4, pp. 209–216, 2004. View at Google Scholar
  117. E. Gitto, C. Romeo, R. J. Reiter et al., “Melatonin reduces oxidative stress in surgical neonates,” Journal of Pediatric Surgery, vol. 39, no. 2, pp. 184–189, 2004. View at Publisher · View at Google Scholar
  118. H. Illnerová, M. Buresová, J. Presl et al., “Melatonin rhythm in human milk,” Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 3, pp. 838–841, 1993. View at Publisher · View at Google Scholar
  119. J. Cubero, D. Narciso, S. Aparicio et al., “Improved circadian sleep-wake cycle in infants fed a day/night dissociated formula milk,” Neuroendocrinology Letters, vol. 27, no. 3, pp. 373–380, 2006. View at Google Scholar
  120. S. Aparicio, C. Garau, S. Esteban, M. C. Nicolau, M. Rivero, and R. V. Rial, “Chrononutrition: use of dissociated day/night infant milk formulas to improve the development of the wake-sleep rhythms. effects of tryptophan,” Nutritional Neuroscience, vol. 10, no. 3-4, pp. 137–143, 2007. View at Publisher · View at Google Scholar